Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2024-10-17 00:00:00 ET · period of report 2024-10-15 · accession 0000950170-24-115380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DTI | 2024-10-17 | 2024-10-15 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $62.32 | +28.5K | 112.2K | +34% | +$1.78M |
| DMTI | 2024-10-17 | 2024-10-15 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $74.12 | -28.5K | 83.7K | -25% | -$2.11M |
| DTI | 2024-10-17 | 2024-10-15 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | -28.5K | 57.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-10-15 | M | A | 28,512 | $62.32 | 112,233 | I By a trust | — | — | (F1) The shares held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 reported in the Form 4 filed for the Reporting Person on June 25, 2024 were incorrectly reported as 83,271. The correct amount was 83,721 at that time, and the shares held reported herein reflect the corrected amount. (F2) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 2 | Common | Class A Common Stock | 2024-10-15 | S | D | 18,696 | $73.90 | 93,537 | I By a trust | — | — | (F3) The shares were sold in multiple transactions at prices ranging from $73.38 to $74.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F2) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 3 | Common | Class A Common Stock | 2024-10-15 | S | D | 9,816 | $74.55 | 83,721 | I By a trust | — | — | (F4) The shares were sold in multiple transactions at prices ranging from $74.38 to $74.74, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F2) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2024-10-15 | M | D | 28,512 | $0.00 | 57,888 | I By a trust | $62.32 · — to 2024-12-15 | 28,512 Class A Common Stock | (F2) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 (F6) This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares. |